Phathom Pharmaceuticals, Inc. · NASDAQ:PHAT
Carlyle Group Inc.'s stake in Phathom Pharmaceuticals, Inc. fell to 4.90% (Schedule 13G/A)
Event Aug 28, 2025 · Filed Aug 28, 2025
Carlyle Group Inc.'s stake in Phathom Pharmaceuticals, Inc. fell to 4.90%, 3,496,808 shares, as a passive investor on Aug 28, 2025. Filed Aug 28, 2025 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 3,496,808
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 11 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Carlyle Group Inc. | 4.90% | 3,496,808 |
| Carlyle Holdings I GP Inc. | 4.90% | 3,496,808 |
| Carlyle Holdings I GP Sub L.L.C. | 4.90% | 3,496,808 |
| Carlyle Holdings I L.P. | 4.90% | 3,496,808 |
| CG Subsidiary Holdings L.L.C. | 4.90% | 3,496,808 |
| TC Group, L.L.C. | 4.90% | 3,496,808 |
| Carlyle Investment Management L.L.C. | 4.90% | 3,496,808 |
| Carlyle Genesis UK LLC | 4.90% | 3,496,808 |
| Abingworth LLP | 4.90% | 3,496,808 |
| Abingworth Bioventures 8 LP | 2.90% | 2,061,702 |
| Abingworth Bioventures VII LP | 2.00% | 1,435,106 |
Source
Related
- Phathom Pharmaceuticals, Inc.
- Carlyle Group Inc.
- Phathom Pharmaceuticals, Inc. shareholders
- Form 4 · Narula Sanjeev · Oct 8, 2026
- Form 4 · Breedlove Robert Charles · Sep 8, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 20, 2026
- Form 4 · Breedlove Robert Charles · Jul 16, 2026